AU Patent

AU2003272608A1 — Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson's disease

Assigned to University of Utah Research Foundation Inc · Expires 2004-04-08 · 22y expired

What this patent protects

Patent listed against valbenazine-tosylate.

Drugs covered by this patent

valbenazine-tosylate (VALBENAZINE TOSYLATE)

Patent Metadata

Patent number: AU2003272608A1
Jurisdiction: AU
Classification: —
Expires: 2004-04-08
Drug substance claim: No
Drug product claim: No
Assignee: University of Utah Research Foundation Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.